Wellcome Trust gives Polyphor CHF 2.3 million for antibiotic development
Polyphor has received a CHF 2.3 million award from the Wellcome Trust to advance the development of broad-spectrum, Gram-negative pre-clinical product candidates.
List view / Grid view
News
BMBF funds Zika vaccine research group at LMU
The research group will explore novel approaches to vaccine development, focusing on the Zika virus.
Genmab appoints Judith Klimovsky as Chief Development Officer
The biotechnology company Genmab announced today the appointment of Judith Klimovsky, MD, as Executive Vice President and Chief Development Officer.
Molecular Devices introduces SpectraMax iD3 Multi-Mode Microplate Reader
Molecular Devices announced the launch of the new SpectraMax® iD3 Multi-Mode Microplate Reader, a cornerstone of a complete laboratory solution to help you expand the boundaries of your research capabilities...
Quotient Clinical acquires SeaView Research, the specialist clinical pharmacology business
Quotient Clinical announces that it has acquired SeaView Research, expanding its operations into the USA...
How to stop pain from serious burns using epigenetics
The unpleasant sensation sparked by the nervous system when confronted with a harmful stimulus can be alleviated by blocking a genetic marker that switches off the activity of the neurons involved.
Breath test could help detect stomach and oesophageal cancers
A test that measures the levels of five chemicals in the breath has shown promising results for the detection of oesophageal and stomach cancers, in a large patient trial.
‘Love hormone’ used a drug lead for inhibiting preterm labour
A team of scientists from Austria, Australia, Denmark, England and the Czech Republic, led by Christian Gruber from the MedUni Vienna's Institute of Pharmacology, managed to isolate a neuropeptide from ants that is very similar to the human love hormone oxytocin, and the closely related hormone vasopressin.
Colorectal metastases biomarker predicts patient survival
Liver metastases are formed from cancer cells that have originated in other organs and migrated to the liver via the bloodstream.
Oncolytic Virotherapy Europe Congress returns to London
The Oncolytic Virotherapy Europe Congress is the only conference in Europe dedicated specifically to the Oncolytic Virotherapy and converting research into the next generation of clinically-relevant virotherapeutics.
Lorenz Mayr joins Drug Discovery 2017 speaker lineup
Lorenz Mayr, esteemed Vice President and Global Head of Biological Reagents and Assay Development at AstraZeneca will be joining the expert speaker lineup for the launch conference on Drug Discovery. The event takes place on 27 and 28 April 2017 in London.
Update on Charles River’s collaboration with Moderna Therapeutics
Charles River Laboratories has provided a progress update related to its support of Moderna Therapeutics’ nonclinical discovery and development efforts...
SMi release exclusive interview ahead of Paediatric Clinical Trials 2017
‘Paediatric Clinical Trials’ returns to London on 20th-21st March 2017 and is delighted to have Larissa Kerecuk as one of the keynote speakers.
AMR exclusive: New innovations in microbome-targeted products
24 January 2017 | By
Author and Scientific Director Jean de Gunzburg, from Da Volterra, will present keynote speech at 19th annual Superbugs summit...
Scientists initiate first ethical guidelines for organs cultivated in vitro
Organ models, which are cultivated in the laboratory from human stem cells and grow into living tissue, are one of the most important scientific breakthroughs of recent years.